PRO 2000

Drug Profile

PRO 2000

Alternative Names: Naphthalene sulfonate polymer (PRO 2000); PIC 024; PRO 2000/5 gel; X-CD4

Latest Information Update: 10 Mar 2010

Price : $50

At a glance

  • Originator Procept
  • Developer Endo Pharmaceuticals Solutions
  • Class Antivirals; Naphthalenesulfonates; Polymers; Small molecules
  • Mechanism of Action CD4 antigen inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 01 Mar 2010 Discontinued - Phase-III for HIV infections in Uganda (Vaginal)
  • 01 Mar 2010 Discontinued - Phase-III for HIV infections in South Africa (Vaginal)
  • 01 Mar 2010 Discontinued - Phase-II for HIV infections in Malawi (Vaginal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top